Zhuhai R&D and Production Base
Located in the Biomedicine Industrial Park in the Jinwan District of Zhuhai, The new R&D and production base covers a total area of 96,000 square meters, with an investment of RMB390 million for the first phase of the development. It is an industry-advanced, garden style, energy-efficient and modern plant consisting of four main areas including production and R&D, warehouse logistics, administrative office, and living facilities, and equipped with various automated and intelligent equipment in R&D, quality control, production and storage. It has also established an inspection and testing system based on pharmacopoeia standards in China, the United Kingdom and the United States, and has obtained the Chinese GMP certification to ensure quality control, energy efficiency, emission reduction, and advanced management. The Zhuhai Base attaches great importance to drug innovation and R&D, and owns a number of invention patents. The Valsartan capsules was rated as a famous high-tech product of Guangdong Province and a winner of the China Patent Award, passed the conformance assessment in 2020 and subsequently came in first place in the nation’s Third Round of Centralized Drug Procurement with Target Quantity. The Company has secured nationwide distribution for this product.
Kunming R&D and Production Base
Mengsheng Pharmaceutical is located in Kunming Economic and Technology Development Zone, spanning an area of 17. 466 square metres, with production facilities of advanced lyophilised powder technology recognised by the new national GMP standard. Its key products include Cerebroprotein Hydrolvsate Injection (III), Vinpocetine Injection, Aceglutamide Injection and Methionine Vitamin B1 Injection. Cerebroprotein Hvdrolvsate Injection (III) is a prescribed biochemical medicine with core ingredient extracted from swine brain tissues, which facilitates growth of cerebro-neuro cells and recovery of cerebral functions. The production process was patented by the State Intellectual Property Office in China, thereby reaching international standard of its product category. Its standard of excellence and market share are well ahead of industry players in China, with global presence such as India.
Global Sales Network
Tianda Pharmaceuticals emphasizes on global marketing strategy. In China, the Company has established a sizeable marketing and sales team which coupled with distributors in various provinces and municipalities to sell its products throughout the country. The Company also formulated strategic plans for sales and marketing in China which are being implemented progressively. For global market, through HK headquarters and branches in various cities and countries like Australia or working partners, Tianda Pharmaceuticals has gradually built up an international sales team with direct sales people, coupled with distributors from different parts of the world. Tianda Pharmaceuticals is dedicated to setting up a worldwide sales network that covers major markets for the purpose of achieving its strategy in market globalization.
